n (%) | Progression | Rapid progression | |||||
---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | ||
C1MH | 116 (44.4) | 2.05 | 1.13 to 3.71 | 0.018 | 3.74 | 1.36 to 10.3 | 0.011 |
C1MV | 51 (19.5) | 1.29 | 1.07 to 1.55 | 0.0070 | 1.67 | 1.27 to 2.19 | 0.0003 |
CRPH | 116 (44.4) | 2.08 | 1.12 to 3.84 | 0.020 | 4.13 | 1.48 to 11.5 | 0.0067 |
CRPV | 50 (19.2) | 1.33 | 1.11 to 1.60 | 0.0021 | 1.73 | 1.31 to 2.27 | 0.0001 |
C1MH + CRPH | 92 (35.2) | 2.51 | 1.27 to 4.98 | 0.0085 | 5.87 | 1.85 to 18.6 | 0.0026 |
C1MH + CRPV | 46 (17.6) | 3.82 | 1.89 to 8.51 | 0.0011 | 13.1 | 3.6 to 48.0 | 0.0001 |
C1MV + CRPH | 51 (19.5) | 3.14 | 1.44 to 6.86 | 0.0046 | 9.43 | 2.83 to 31.4 | 0.0003 |
C1MV + CRPV | 36 (13.8) | 3.64 | 1.57 to 8.44 | 0.0026 | 11.5 | 3.3 to 40.7 | 0.0001 |